Kai Wang

Loss of heterozygosity related to TMB and TNB may predict PFS for patients with SCLC received the first line setting

Chenyue Zhang, Haiyong Wang, Kai Wang, 2021, Journal of translational medicine.

The Correlation Between Immune Invasion and SARS-COV-2 Entry Protein ADAM17 in Cancer Patients by Bioinformatic Analysis

Junjiang Fu, Jiayue He, Jiewen Fu, 2022, Frontiers in Immunology.

Integrative computational approach identifies immune‐relevant biomarkers in ulcerative colitis

Kai Wang, Xinbao Yin, Yulian Zhang, 2021, FEBS open bio.

Non-small-cell lung cancer patients harboring TP53/KRAS co-mutation could benefit from a PD-L1 inhibitor.

Chenyue Zhang, Jiamao Lin, Haiyong Wang, 2022, Future oncology.

Orchestrating smart therapeutics to achieve optimal treatment in small cell lung cancer: recent progress and future directions

Chenyue Zhang, Haiyong Wang, Chenxing Zhang, 2023, Journal of Translational Medicine.

FTO-mediated autophagy inhibition promotes non-small cell lung cancer progression by reducing the stability of SESN2 mRNA

Kai Wang, Zhiqiang Mei, Xiaoyan Liu, 2024, Heliyon.

Adenosine in cancer immunotherapy: Taking off on a new plane.

Chenyue Zhang, Kai Wang, Haiyong Wang, 2023, Biochimica et biophysica acta. Reviews on cancer.